Results 131 to 140 of about 88,642,428 (226)

Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis. [PDF]

open access: yesInt J Mol Sci, 2022
Adam de Beaumais T   +7 more
europepmc   +1 more source

Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6-Mercaptopurine Treatment. [PDF]

open access: yesClin Transl Sci
Khaeso K   +8 more
europepmc   +1 more source

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. [PDF]

open access: yesCochrane Database Syst Rev
Hasskamp J   +3 more
europepmc   +1 more source

Characteristics of 6-Mercaptopurine-Resistant L1210 Cells Newly Developed by in vivo and in vitro Treatment with 6-Mercaptopurine [PDF]

open access: yes
6-Mercaptopurine-resistant sublines of L1210 cell were obtained by in vivo and in vitro treatment with 6-mercaptopurine. These 27 sublines were classified into high- and low-resistant sublines.
Mitsuhashi, Susumu   +5 more
core  

In vitro cytotoxicity analysis on patient-derived PBMCs to predict 6-mercaptopurine therapy response in children with acute lymphoblastic leukemia

open access: yes
371-3796-Mercaptopurine (6-MP) is a critical medication used in the remission-maintenance phase of pediatric acute lymphoblastic leukemia (ALL). Mercaptopurine has a narrow therapeutic index with treatment-related toxicities and resistance as major ...
Manda, Sasidhar V   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy